Keywords
  • Investment Case
  • microarray patches
  • Global
  • discounted cash flow
  • innovation
  • Measles-rubella
— Ongoing

Assess the financial viability for developing and commercializing a Measles, Mumps, and Rubella Microarray Patch

Client
Goal

Understand the key drivers that can impact the financial attractiveness of the development and commercialization of MMR-MAPs.

Result

Interactive discounted cash flow analysis assessing key drivers that can impact the attractiveness of an investment in MMR-MAPs manufacturing facility.

Focus Area
Access